Welcome to our dedicated page for PMGC Holdings SEC filings (Ticker: elab), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking PMGC Holdings鈥� evolution鈥攆rom engineered probiotic obesity therapies to uranium-backed investments鈥攎eans piecing together data scattered across dozens of SEC documents. Each quarter, disclosures blend biotech trial updates, medical aesthetics revenue, and capital deployment news, leaving investors asking how to locate all of it efficiently.
That鈥檚 where Stock Titan steps in. Whether you search 鈥淧MGC Holdings quarterly earnings report 10-Q filing鈥� or 鈥淧MGC Holdings insider trading Form 4 transactions,鈥� you land on a page that our AI has already translated into plain language. AG真人官方-time alerts surface 鈥淧MGC Holdings Form 4 insider transactions real-time,鈥� while concise summaries answer the bigger question: 鈥渦nderstanding PMGC Holdings SEC documents with AI.鈥� From cash-burn trends to fresh 8-K deal announcements, complexity is distilled into clear takeaways.
- Annual insight 鈥� The 鈥淧MGC Holdings annual report 10-K simplified鈥� section highlights pipeline milestones for Northstrive Biosciences and funding details for aesthetic R&D.
- Quarterly pulse 鈥� 鈥淧MGC Holdings earnings report filing analysis鈥� compares segment revenue shifts and R&D spend without digging through tables.
- Event radar 鈥� 鈥淧MGC Holdings 8-K material events explained鈥� flags new fire-prevention or energy investments the moment they post.
- Governance clarity 鈥� Our proxy tools decode 鈥淧MGC Holdings proxy statement executive compensation,鈥� mapping pay to performance across subsidiaries.
- Insider moves 鈥� Instant alerts for 鈥淧MGC Holdings executive stock transactions Form 4鈥� help monitor sentiment before catalytic data releases.
Every document鈥�10-Ks, 10-Qs, S-3s, 8-Ks, Form 4s鈥攆eeds into Stock Titan鈥檚 AI-powered summaries so you can navigate 鈥淧MGC Holdings SEC filings explained simply鈥� and act on insights faster than ever.
PMGC Holdings Inc. reported total assets of $9.38M and cash of $5.68M at June 30, 2025, up from $3.98M at year-end 2024. Equity increased to $9.05M from $6.66M, largely reflecting equity financings during the period and retrospective reverse stock splits reducing share counts. For the six months ended June 30, 2025 the Company recorded a net loss of $2.17M and used $2.69M of cash in operating activities, compared with a $2.81M loss and $3.10M cash used in the prior year period.
The company sold its skincare business (closed January 16, 2025) for consideration including $728,550 in buyer shares and recognized a $39,676 loss on the sale; it also recorded a $129,613 gain on termination of a license agreement. Investments at June 30, 2025 totaled $624,838 (realized loss on sales $371,494; unrealized gain $238,899). Management discloses substantial doubt about going concern and plans to raise financing or acquire cash-generating assets; subsequent to quarter end it completed acquisitions of Pacific Sun Packaging (consideration $1,148,000 plus earnout) and AGA Precision Systems ($650,000).
On 25 Jul 2025, PMGC Holdings Inc. (Nasdaq: ELAB) filed an 8-K disclosing a Secondment Agreement with GB Capital Ltd., a company wholly owned by CEO/CFO/director Graydon Bensler. GB Capital will second its employees to PMGC on an exclusive, as-needed basis; the individuals remain GB employees.
Compensation: PMGC will reimburse GB Capital monthly at hourly rates listed in Exhibit A plus pre-approved extraordinary expenses. GB Capital continues to pay salaries and benefits.
Control & Risk Allocation: PMGC assumes full responsibility for the employees鈥� actions while seconded. The pact includes typical confidentiality, indemnification and liability-limit clauses.
Termination: PMGC may end any employee鈥檚 secondment with 15 days鈥� notice (immediate for misconduct) and may terminate the entire agreement with 30 days鈥� notice; GB Capital requires 90 days. Either party can terminate on 10 days鈥� notice for uncured breach.
Governance Note: Because the counterparty is owned by the CEO, this is a related-party transaction; dollar amounts of anticipated reimbursements are not disclosed. No financial results, guidance changes or capital actions were reported. A press release dated 30 Jul 2025 is furnished as Exhibit 99.1.
PMGC Holdings (NASDAQ: ELAB) filed an 8-K report disclosing the release of a press release on June 24, 2025, under Regulation FD. The company, headquartered in Newport Beach, CA, is classified as an emerging growth company.
Key details from the filing:
- Filed under Item 7.01 Regulation FD Disclosure
- The press release is furnished as Exhibit 99.1
- Document signed by Graydon Bensler, serving as CEO, President and Director
- Company has common stock listed on Nasdaq with $0.0001 par value
- Has not elected to use extended transition period for new accounting standards
Note: The specific content of the press release is not detailed in this 8-K filing. The furnished information is explicitly stated as not "filed" under Section 18 of the Exchange Act and not incorporated by reference into future filings unless specifically indicated.
FAQ
What is the current stock price of PMGC Holdings (elab)?
What is the market cap of PMGC Holdings (elab)?
